Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
531599 | BSE
-8.50
-2.07%
Healthcare
Drug Manufacturers - Major
31/03/2023
08/12/2023
403.05
412.50
415.50
399.70
FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments including anti-infective gastrointestinal ophthalmological vitamins/minerals/dietary supplements cardiac anti-diabetes respiratory gynecology dermatology analgesics and others; and oral rehydration salts. It provides specialized formulations primarily under the Zifi Electral Enerzal Vitcofol Pyrimon Zocon Zoxan Zathrin Zipod Zefu Cotaryl and Mycoderm brand names. The company also offers anti-oxidants balanced energy drinks and vitamins and nutraceuticals under the Enerzal Humyl Mum Mum 1 Prosoyal Simyl-LBW Simyl-MCT and Zefrich brands. In addition it provides various active pharmaceutical ingredients. FDC Limited was founded in 1936 and is headquartered in Mumbai India.
View LessPositive Momentum
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Sharpe Ratio (> 1.2)
Weakness based on declining price with high volume
Smallcap (300M - 2B USD)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
20.8%1 month
31.2%3 months
29.0%6 months
32.0%18.54
0
3.27
0.18
0.15
11.47
3.78
0
3.55B
60.37B
723.75M
0.48
24.29
64.00
7.30
19.58
0
0
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
33.55
Range1M
67.90
Range3M
79.80
Rel. volume
1.19
Price X volume
10.29M